In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Myelosan Drug Master File in Korea (Myelosan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Myelosan. The MFDS reviews the Myelosan KDMF as part of the drug registration process and uses the information provided in the Myelosan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Myelosan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Myelosan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Myelosan suppliers with KDMF on PharmaCompass.